Nerve agents (NAs) are potent organophosphorus (OP) compounds with applications in chemical warfare. OP compounds act by inhibiting acetylcholinesterase (AChE). Soman (O-pinacolyl methylphosphonofluoridate) is one of the most potent NAs. It is well known that small doses of NAs can be lethal, and that even non-lethal exposure leads to long-term mental debilitation/neurological damage. However, the neuropathology following exposure to sub-lethal nerve agents is not well understood.
Introduction
Nerve agents (NAs) are potent organophosphorus (OP) compounds with applications in chemical warfare and categorized as weapons of mass destruction. Less potent forms of OPs, including parathion and malathion, are commonly used as pesticides. NAs, which include soman, sarin, tabun, and VX are a significant and current threat to military and civilian populations, because of the potential to cause mass casualties (Ganesan et al., 2010) . Despite a ban under the Chemical Weapons Convention Implementation Act, sarin was released in August of 2013 in Syria, killing 1400 people (Dolgin, 2013) and potentially exposing 1000 0 s to an acute dose.
It is clear that NAs are lethal, however, the pathophysiological neurological changes resulting from a sub-lethal exposure are not well characterized or understood. Repeated acute exposure to OP pesticides has been shown to affect information processing, verbal and visual attention, problem-solving, and motor dexterity (Dassanayake et al., 2007; Rosenstock et al., 1991; Steenland et al., 1994) . Studies involving agricultural communities have shown that exposure to long-term low-levels of OP pesticide results in changes to neurological structures in developing children (Rauh et al., 2012) . In addition, studies involving victims exposed to NAs have shown changes in regional white matter volume (Chao et al., 2011; Heaton et al., 2007; Yamasue et al., 2007) and grey matter volume (Chao et al., 2011 (Chao et al., , 2010 . Victims of sarin exposure have reported visual, cognitive and motor dysfunction for up to 5 years after poisoning (Kawana et al., 2001) . To better understand the neurological effects of NAs at a sub-lethal dose, we exposed rats to soman.
Somanwasselectedforitsfastaction andcomplexityof treatment, due to the rapid aging of the agent-acetylcholinesterase (AChE) complex (Worek et al., 2004) . Initial binding of soman to the AChE active site is a reversible process. However, after 2-2.5 min (Worek et al., 2004) soman undergoes a secondary reaction where the pinacolyl bond is cleaved and permanently binds to the AChE active site (Jokanovic, 2001; Zilker, 2005) . Inhibition of AChE results in an accumulation of acetylcholine (ACh) in the synapse causing cholinergic hyperactivity, which leads to a wide range of symptoms, including lacrimation, fasciculation, paralysis, generalized convulsive seizures, and respiratory failure . Soman also causes generalized convulsive seizures that can potentially develop into a condition known as status epilepticus (Lallement et al., 1998; Newmark, 2004; Petras, 1994; Shih and McDonough,1997) , which can last for hours (Koplovitz and Skvorak, 1998) . Status epilepticus is a life threatening condition defined by seizures lasting more than 5 min or having multiple seizure episodes without recovering consciousness (Lowenstein et al., 1999) .
Previous research with soman in animal models has shown seizures to be a contributing factor in neurological damage. In other studies, either through innate tolerance or anti-seizure medication, in the absence of convulsive seizures, no neurological degeneration was observed (Apland et al., 2010; Baille et al., 2005; Guo et al., 2015; Lallement et al., 1993; McDonough et al., 1987) . When convulsive seizures were terminated within 20 min, minimal neuronal loss was seen (Baille et al., 2005; Lallement et al., 1993) , indicating the presence and duration of seizures to be a critical factor in soman related neurological damage.
Seizures induced by soman cause neurological damage through excitotoxicity (Fujikawa et al., 2000; Lallement et al., 1993; Olney et al., 1974) . The initiation of seizures is triggered by the excess accumulation of ACh within the synapses , which in turn causes glutamatergic neurons to release glutamate activating a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. Intense activation of AMPA receptors is followed by the activation of Nmethyl-D-aspartate (NMDA) receptor and enhanced calcium entry. The large influx of calcium results in neurons to be in a state of hyperexcitability, further facilitating the propagation and maintenance of seizures. The intense activation of NMDA receptors can activate a cell death pathway, leading to neuronal cell death (Fujikawa et al., 2000; Lallement et al., 1993) .
Measurements of pO 2 provide information about metabolic imbalance in the brain, which in turn can lead to neuronal damage. By directly measuring pO 2 , we can get an indication of the balance between oxygen delivery (cerebral blood flow or CBF) and cerebral metabolic rate of oxygen (CMRO 2 ). We developed a method to measure regional pO 2 in the brain using chronically implanted fiber-optic oxygen sensors in awake and freely moving rats (OrtizPrado et al., 2010) . This method allows for the measurement of pO 2 without anesthesia or other stresses (handling or restraint) that can potentially alter related physiological responses.
The objective of this study was to measure pO 2 in the rat brain after soman-induced convulsive seizures. This paper is the first to measure pO 2 changes before, during, and after soman-induced convulsive seizures in awake and freely moving rats. Brain oxygenation was directly measured in the cortex and hippocampus, which are areas selected for their sensitivity to NA related neurological damage (Abdel-Rahman et al., 2002; Petras, 1994) .
Materials and methods

Animals
Animal care protocols were approved by the University of Calgary Animal Care Committee and meet the Canadian Council of Animal Care (CCAC) guidelines. Twelve male Sprague-Dawley rats were obtained from Charles River Laboratories (Montréal, QC, Canada) weighing 200-350 g. Rats were housed in the University of Calgary Animal Care Facility (Calgary, AB, Canada) with a 12-h light/dark cycle. Each cage housed two rats until probe implantation. Rats were handled for an additional 2-3 days to acclimate to human touch. Surgical implantation of probes was completed following acclimation. Following the probe implantation, rats were housed in individual cages with access to food and water ad libitum. Rats were closely monitored on a daily basis by staff for general health status.
pO 2 probe implantation
Fiber-optic probes were implanted in the cortex and hippocampus via microsurgical methods. The fiber lengths were 4 mm for the hippocampus and 3 mm for the cortex. Animals were anesthetized with isoflurane via inhalation prior to surgery and maintained on 70% N 2 , 30% O 2 , and 2% isoflurane during the surgical procedure. Temperature and respiration rate were monitored and maintained over the course of implantation. Scalp was shaved and sterilized with iodine solution, a midline incision was made and the skin was retracted laterally to expose the skull. Holes were drilled through the skull at stereotaxic coordinates relative to the bregma. Cortex coordinates: +1 mm anterior/ posterior, +1.5 mm medial/lateral, and À2 mm from the top of the skull. Hippocampus coordinates: À4 mm anterior/posterior, À3.5 mm medial/lateral, and À3 mm from the top of the skull. To further secure the probes, 3 additional holes were drilled and implanted with plastic screws. The probes and screws were secured with dental cement and molded into a head cap. The retracted skin was secured to the head cap with cyanoacrylate glue. Rats were administered buprenorphine (0.1 mg/kg; subcutaneous) post-surgery for analgesic control. Rats were monitored closely during surgical recovery to ensure the head cap was secure and discomfort was minimized. Rats were given two doses of buprenorphine (0.1 mg/kg) per day for up to three days postsurgery and were monitored minimum of twice daily for general health status and any signs of pain or stress.
Drugs
Soman (CAS 96-64-0) was diluted in isopropyl alcohol (SigmaAldrich, Millwaukee, WI, USA) and then sterile saline (0.9% NaCl, Baxter, Canada) to the maximum concentration required for the heaviest rat used on the day of exposure. A dose of 80-90 mg/kg was used in this study based on a pilot study that showed this dose consistently resulted in convulsive seizures. This dose is 0.72-0.82xLD50 based on a published LD50 of 110 mg/kg subcutaneous (Shih et al., 1990) .
The oxime, HI-6 dimethanesulfonate (CAS 144252-71-1) was provided by the Defence Research and Development Canada (DRDC) Suffield Research Centre. A dose of 125 mg/kg was prepared in 0.9% sterile saline. The same dose of HI-6 was used pre-and post soman injection.
Atropine Methyl Nitrate (AMN) was purchased from Sigma Aldrich (Milwaukee, WI, USA). A dose of 20 mg/kg of AMN was prepared in 0.9% sterile saline. The same dose of AMN was used pre-and post soman injection.
Magnetic resonance imaging
Rats were imaged after probe implantation to confirm the relative probe location and check for intracranial bleeding 24 h after surgery. Imaging was done with a 9.4T MRI and a Bruker Avance console (Bruker Biospin GmbH, Rheinstetten, Germany).
Rats were secured in place with ear bars and ventilated with 70% N 2 , 30% O 2 , and 1.5-2.5% isoflurane. Body temperature (36.5 to 37 C) and respiration rate (60-80 breaths/min) were monitored during imaging. Imaging was performed with a 20 mm surface coil using a rapid acquisition with relaxation enhancement (RARE) T 2 -weighted sequence: TR = 2500 ms, TE = 36 ms, flip angle = 180 , RARE factor = 8, averages = 1, matrix = 384 Â 384, 9 slices, and thickness of 0.5 mm. Total acquisition time was 20 min per rat.
Experimental design
Fiber-optic oxygen probes (Oxford Optronix, Oxford, UK) (Fig. 1a) were used to measure cortical and hippocampal pO 2 . The oxygen probes utilize a platinum fluorophore embedded in silicone rubber at the tip of an optical fiber with an approximate diameter of 250 mm.
A short pulse of LED light (525 nm) is sent through a fiber-optic cable, which excites a platinum-based fluorophore at the end of fiber-optic oxygen probes, which emits at 650 nm. The platinumbased fluorophore is quenched by oxygen around the probe tip and the decay time is inversely proportional to oxygenation.
Each rat was implanted with 2 probes, one in the cortex and one in the hippocampus (implantation coordinates were standardized for all rats based on bregma). A structural MRI was obtained after surgery to confirm the location of the pO 2 probes and check for intracranial bleeding. Rats were monitored for 5-7 days prior to initial baseline measurement to allow for healing around the implant.
During pO 2 measurements, fiber-optic cables were attached to the implanted oxygen-sensing probes, which protrude from the implant (Fig. 1b) . Animals were allowed to explore the measurement cage for 10 min before collection of pO 2 data at 1 Hz. The rats were awake and freely moving in an empty cage over the course of the measurement period. Fiber-optic cables were supported on a lab stand to minimize tension on the head cap.
Baseline pO 2 measurements were obtained for 15 min on 4 consecutive days (Fig. 2) . The first measurement day was ignored in case of a training effect. A 15-min baseline was taken on the day of soman injection. During measurements, background stimuli (movement, noise) were kept to a consistent minimum. To reduce potential variability between rats, each rat was measured within 1 h at the same time of day. In addition, the first 5 min of each baseline measurement was discarded in case there was a handling effect causing stress. In total, we evaluated three baseline measurements of 10 min for each rat, which were averaged to one data point per baseline measurement.
Pretreatments of HI-6 dimethanesulfonate and atropine methyl nitrate (AMN) (125 mg/kg and 20 mg/kg; intraperitoneal) were coadministered 20-30 min before soman exposure to increase survival of rats (Fig. 2 ). HI-6 is an acetylcholinesterase reactivator (Jokanovic and Stojiljkovic, 2006) and has been shown to reduce mortality without effecting seizure occurrence (McDonough and Shih, 1993) . AMN is an acetylcholine muscarinic receptor antagonist and reduces soman-induced peripheral symptoms. HI-6 and AMN do not readily cross the blood-brain barrier and therefore do not interfere with the central effect of soman (Shih et al., 1991) . Pretreatment pO 2 values were measured 20 to 30 min after pretreatment injection until soman administration.
For soman injection, rats were temporarily disconnected from the Oxylite and anesthetized with 5% isoflurane for approximately 3-5 min. Anesthetized rats were moved into the fume hood and injected with soman (80-90 mg/kg; subcutaneously). The injection site was immediately scrubbed with Reactive Skin Decontamination Lotion (RSDL). Anesthesia was discontinued directly after soman injection and rats were reconnected to the Oxylite and pO 2 measurements and video recordings were taken.
Short-term measurements were taken directly after soman injection for 30-60 min (Fig. 2) . The first set of rats we measured was for 60 min. In all of these, the peak oxygenation occurred before 30 min. In order to increase our data collection throughput and reduce stress, we subsequently reduced the initial post soman recording to 30 min. Following short-term measurement, rats were transported into an empty cage to be continuously monitored and rated based on physical symptoms overnight (Table 1) . To minimize mortality rate, additional treatment of AMN (20 mg/ kg; i.p) was given every 20-30 min for up to three doses. Treatments were provided to minimize muscarinic effects of soman exposure.
A video camera was mounted on a stand to monitor behavioral seizure activity in the rats. Recordings began immediately following soman-injection and were stopped when pO 2 measurements were complete. The video recording was later analyzed to confirm the onset of soman-induced convulsive seizures in relation to pO 2 measurements. Observations of convulsions have been used to confirm the occurrence of seizures (Racine, 1972) .
A final long-term measurement was taken for 15 min, 10-24 h after soman injection and rats were sacrificed immediately after (Fig. 2) . To preserve brain tissue, the rats were perfused and fixed.
Histology
Histology was performed to determine exact probe location as MR images only provide a relative position. Rats were euthanized with Euthanyl (200 mg/kg i.p) for transcardial perfusion with 100 ml of 1X PBS, then 100 ml of 4% paraformaldehyde (4% PFA). Brains were carefully excised and fixed overnight in 4% PFA for up to 48 h. 4% PFA solution was replaced with 30% sucrose solution and remained in sucrose solution until sectioning. Tissue was embedded in optimal cutting temperature (OCT) compound and sectioned at 20 mm. Sections were stained with hematoxylin and eosin (H&E) to assess probe location.
Data analysis
Video recording of the pO 2 measurement after soman injection was reviewed for a rating 5 on the symptom severity (Table 1) to estimate the time point of onset of soman-induced convulsive seizures.
The total recording time was 140 min. Baseline pO 2 was measured on 3 consecutive days including the day of injection (30 min). Immediately following the last baseline measurement, pretreatment was injected and pO 2 was measured for a total of 20-30 min, but only the last 10 min were averaged. After soman Table 1 Rating system to assess the severity of soman related symptoms. Suffield Rating Scale.
Symptoms
Rating 1 Normal Rating 2 One of the following signs: fasciculations, tremors, lacrimation, mouth movement, salivation, vocalizations, abnormal mobility, or abnormal responsiveness Rating 3 2 or more of the above signs Rating 4 Any of the above signs and partial paralysis (fore OR hind limbs affected) Rating 5 Any of the above signs, full body paralysis (unable to right hind or front limbs), severely labored breathing, and/or seizures/convulsions Rating 6 Unexpected Death injection, pO 2 was recorded for 30-60 min and at peak, a total of 1-min was averaged for the short-term. The rat was disconnected from the Oxylite and placed in an empty cage until a final measurement at 10 to 24 h (long-term) for 10 min.
Heterogeneity in baseline oxygenation was expected between rats. Mean baseline and standard deviation was calculated using approximately 30-min of baseline pO 2 recordings on 3 consecutive days prior to pretreatment and soman injection. Any value above or below two standard deviations from the average baseline was defined as being significantly different from baseline.
A comparison between different time points was performed by averaging the pO 2 at each time point. All statistical analysis was performed using IBM SPSS Statistics. A one-way repeated measure analysis of variance (ANOVA) was used to compare the baseline, pretreatment, short-term, and long-term, with a Tukey post-hoc test to test for between group differences. If the F-test for normal variance was not significant, a non-parametric test (Friedman) was used. For the cortex pO 2 , a Friedman test followed by a Wilcoxon rank sum test was used. The hippocampal pO 2 was further evaluated by a Tukey test. p-values < .05 were considered statistically significant.
The baseline pO 2 between the cortex and hippocampus was compared for each rat. In addition, the timing to peak oxygenation was compared between the cortex and hippocampus. A paired ttest was performed where a p-value < .05 was considered statistically significant.
Results
Behavioral effects of Soman
Soman induced convulsive seizures were assessed based on behaviour. Within 5 min after soman exposure, rats exhibited a symptom rating of 2 (Table 1 ; facial movement and salivation). Ten minutes following exposure, all rats exhibited signs rating of 5 (Table 1 ; convulsive seizures). After the convulsive seizures had terminated, rats exhibited a symptom rating of 4. Most had splayed hind limbs throughout the short-term measurement (within 30-60 min post-soman injection). Even at the time of euthanasia (after 10-24 h post-soman injection), most had rhythmic head movement. Three unexpected deaths occurred following soman exposure, one before the 1 h and two before the 24 h marks, most likely from respiratory difficulty due to reduced respiration and excessive secretions. However, all available data from these rats were included in the pO 2 analysis.
Imaging probe location
MRI showed that all probes were located in the region of interest (cortex and hippocampus). Representative sections of the cortex and hippocampus are shown in Fig. 3a and b , respectively. Histology confirms that the probes were located in the cortex and hippocampus ( Fig. 3c and d) .
Cortex pO 2 measurements
During baseline measurements in the cortex (n = 10), the baseline pO 2 remained relatively stable over time for each rat ( Fig. 4a-j) . Variation in the mean baseline pO 2 between rats ranged from 25.9 AE 4.2 mmHg to 45.5 AE 6.1 mmHg (mean AE SD) ( Table 2) as expected (Johnson et al., 2016; Ortiz-Prado et al., 2010; Schilte et al., 2015) . Mean cortical pO 2 from 10 rats was 32.4 AE 6.3 mmHg.
Cortical pO 2 during the 10 min of pretreatment is shown in Fig. 4a-j (yellow) . During most of the pretreatment, the cortical pO 2 was within two standard deviations from the baseline in all rats ( Fig. 4a-j) .
Shortly after soman injection, there was a large increase in cortical pO 2 to above two standard deviations from the mean baseline in every rat. The largest increase was 43.8 mmHg (Fig. 4c , Table 2 ). Upon seizure onset (based on observed convulsions), pO 2 began to decline (arrows, Fig. 4a-j) . 40-60 min post soman injection; pO 2 generally remained elevated over baseline (data not shown). Cortical pO 2 in two rats returned to near baseline values, within two standard deviations of the mean baseline ( Fig. 4e and g ) within 40 min. Two rats died unexpectedly and values are shown in Fig. 4d and f. Cyclical large amplitude changes in cortical pO 2 could be observed in every rat.
Long-term cortical pO 2 measurements (10-24 h post-soman injection) were variable between rats (n = 6/10). Due to the severity of symptoms, two rats were measured at 10 h and immediately euthanized. Cortical pO 2 10 h post soman injection (n = 2/10) did not show any significant changes from the mean baseline ( Fig. 4a  and b) . At 24 h (n = 4/10), two of the four rats had significantly elevated pO 2 with a decreasing trend ( Fig. 4g and h ), while the other two rats did not show a significant difference between baseline and 10 h post-soman injection pO 2 values ( Fig. 4c and j) . Fig. 6a shows the change in the cortical pO 2 for each time point. When compared to the baseline (n = 10), the short-term (n = 10) exhibited higher pO 2 in the cortex (p = .005). No significance was found between the baseline and pretreatment (p = .285). Furthermore, the long-term (n = 6) showed an increase in cortical pO 2 values 10-24 h post-soman injection compared to the baseline, but this was not statistically significant (p = .075).
Although there are two outliers in the baseline group (Fig. 6a) , pO 2 values for every rat followed the same general trend (Fig. 6b ): Cortical pO 2 remained relatively stable between baseline and pretreatment, followed by a large increase in the short-term assessment. Long-term assessment had more variability as some rats had elevated pO 2 , while others returned to or near baseline values.
Hippocampal pO 2 measurements
Within each rat, the baseline pO 2 remains relatively stable over time in the hippocampus (n = 12) (Fig. 5a-l) . As with the cortex, variation between rats in baseline pO 2 ranged from 13.6 AE 2.3 mmHg to 34.1 AE 3.1 mmHg (mean AE SD) ( Table 2 ). The combined average pO 2 in 12 rats was 21.1 AE 5.5 mmHg.
Measurements of hippocampal pO 2 had small variation within each rat (n = 12) and remained relatively stable (Fig. 5a-l) . Most rats had pO 2 values that remained close to the baseline and within two standard deviations of the mean baseline. However, two had elevated pretreatment pO 2 values and at times above two standard deviations of the average baseline ( Fig. 5d and l) . The majority of pO 2 , measured after pretreatment, did not show significant change compared to the mean baseline, as the pretreatment pO 2 remains within two standard deviations of the mean baseline. Between rats, there is some variability in the pretreatment pO 2 values, ranging from 16.0 AE 4.4 mmHg to 30.3 AE 2.6 mmHg ( Table 2) .
Immediately following soman injection, there is an elevation in the hippocampal pO 2 above two standard deviations from the mean baseline value in most rats ( Fig. 5a-l) . The largest increase in pO 2 was seen in Fig. 5b , and with a change of 49 mmHg (Table 2) . After the onset of convulsive seizures, there was a delayed decrease in pO 2 in some rats (n = 4/12). However, the majority of rats' pO 2 continues to increase after seizure onset followed by a dip in pO 2 (n = 8/12). During the short-term (30-60 min post soman injection), we observed large variation in hippocampal pO 2 measurement ( Fig. 5a-l) . Shortly following the decrease, there was an increase in every rat above two standard deviations until the end of Table 2 Baseline and peak pO 2 in the cortex and hippocampus after soman injection. Each line represents a rat (n = 10). (Mean AE SD, mmHg Two animals were excluded from the hippocampus from cortical probes not working. Short-term peak data are calculated from the peak pO 2 pre-seizure AE 30 s. Baseline is calculated from three consecutive days including on the day of soman injection for a total of 30 min. measurement except for one rat that died during the experiment (Fig. 5f) . In every rat, we observed cyclical large amplitude changes in pO 2 within the hippocampus. Hippocampal pO 2 measurement showed variation between rats during the long-term assessment. At 10 h (n = 2/12) after soman injection, one rat had significantly elevated hippocampal pO 2 above two standard deviations of the mean baseline (Fig. 5a) , while another had long-term pO 2 near the baseline (Fig. 5b) . At 24 h (n = 5/12), four had elevated long-term hippocampal pO 2 above +2xSD (Fig. 5c , g, h, and l) and one had pO 2 near the baseline level (Fig. 5j) .
Hippocampal oxygenation shows a similar trend as the cortex. No significant difference was found between baseline and pretreatment pO 2 values (p = .985). There was a large increase in the short-term measurement (Fig. 7a) . When baseline was compared to peak oxygenation during short-term assessment, short-term measurements were significantly elevated (p < .001). The long-term assessment (10-24 h) had significantly elevated hippocampal pO 2 compared to the baseline (p = .005).
Despite outliers in the baseline and long-term (n = 3), similar trends could be observed in every rat (Fig. 7b) : Each rat had a similar baseline and pretreatment pO 2 , followed by an increase during the short-term measurement. A decreasing trend can be observed in the long-term measurements, which were still elevated compared to the baseline.
Comparison between cortex and hippocampus
The time to peak pO 2 was compared between the cortex and the hippocampus. During baseline measurements, the cortex had a significantly higher pO 2 than the hippocampus (p < .001) ( Table 2 ). The largest difference in pO 2 between the cortex and hippocampus baseline was 21 mmHg ( Table 2 ). The peak pO 2 in the cortex occurred at a similar time to that of seizure onset (based on using behaviour as a marker for seizure onset). The peak pO 2 in the hippocampus was significantly later (n = 8/10) with the timings being 5.8 AE 1.5 min and 8.2 AE 3 min (mean AE SD, p < .01) for the cortex and hippocampus, respectively.
Discussion
Changes in cortical and hippocampal oxygenation after a convulsive dose of soman were measured using chronically implanted fiber optic oxygen probes. We used a novel method Fig. 6 . Combined cortical pO 2 data a) grouped data showing the baseline, pretreatment, short-term peak and long-term data. Baseline (n = 10), pretreatment (n = 10) and long-term (n = 6) values were plotted using a 10 min mean. Short-term peak (n = 10) was the mean including 30 s before and after the peak pO 2 measurement that occurs near the onset of seizure. The black bars show the maximum and minimum. Middle black line indicates the median. Plus signs are outliers. **p .01 (Friedman test with Wilcoxon signed-rank test) b) Cortical oxygenation trend after each treatment. Each individual shape and line indicates one rat. Fig. 7 . Combined hippocampal pO 2 data a) grouped data showing the baseline, pretreatment, short-term peak and long-term data. Baseline (n = 12), pretreatment (n = 12) and long-term (n = 7) values were calculated from a mean of 10 min. Shortterm peak (n = 12) was the mean including 30 s before and after the peak pO 2 measurement that occurs near the onset of seizure. The black bars show the maximum and minimum. Middle black lines indicate the median. Plus signs are outliers. ***p .001 (ANOVA with Tukey-b post-hoc) b) Hippocampal oxygenation trend after each treatment. Each individual shape and line indicates one rat.
to measure oxygenation in vivo without the need for anesthesia and restraints (Ortiz-Prado et al., 2010) . Using this method, we demonstrated that 1) pO 2 increases in the cortex and the hippocampus shortly after injection of a convulsive dose of soman, until a maximum value was recorded prior to seizure onset; 2) after seizure onset, pO 2 declined but usually remained elevated above baseline for at least 60 min post soman exposure; 3) low frequency cycles of high amplitude changes in both cortical and hippocampal pO 2 were observed; and 4) pO 2 remained elevated after 10 to 24 h (long term) in the hippocampus but returned to baseline in the cortex.
Baseline pO 2 measurements
The baseline pO 2 measurements were variable as exemplified by the fact that the cortical pO 2 between rats ranged from 26 to 46 mmHg (Table 2 ). This was the first time that both hippocampal and cortical pO 2 were measured simultaneously in the same rat. Interestingly, the cortex pO 2 (32.4 AE 6.3 mmHg) was higher than the hippocampus (21.23 AE 6 mmHg). The values were within ranges reported previously for the cortex (30.2 AE 3.3 mmHg) (Ortiz-Prado et al., 2010) and hippocampus (18-30 mmHg) (Farrell et al., 2016) . We expect some level of variability between rats as pO 2 values can change depending on conditions including stress level (Paisansathan et al., 2007) , temperature (Gupta et al., 2002) , and neuronal activity (Lindauer et al., 2003) . Variation between subjects has been seen in other studies that measured brain pO 2 (Johnson et al., 2016; Ortiz-Prado et al., 2010; Schilte et al., 2015) .
From soman exposure to seizure onset
Our results show that soman injection causes hyperoxygenation in the cortex and the hippocampus (Table 2) . Soman inhibits AChE, which will cause an accumulation of ACh in the synapse, leading to sustained firing of cholinergic neurons and induce a state of hyperexcitability. Hyperexcited neurons have an increased CMRO 2 (Sheth et al., 2004) . One would expect that if there is an increase in CMRO 2 there would also be an increase in CBF (Buxton et al., 1998) and pO 2 (Leniger-Follert, 1985; Offenhauser et al., 2005) . Thus, this initial increase in pO 2 may reflect an increase in CMRO 2 caused by increased neuronal excitability.
There is an additional increase in pO 2 in the cortex (and often in the hippocampus), associated with the onset of soman related symptoms. This increase in pO 2 would be expected, as AChE becomes inhibited and more neurons are stimulated to a hyperexcitable state. As cholinergic neurons are stimulated, excitatory projection neurons such as glutamatergic neurons are recruited, CMRO 2 and CBF increase even more and pO 2 rises.
Although it is hypothetical, it may be interesting to keep in mind that increased metabolism can increase oxidative stress. This could cause membrane and mitochondrial damage (Baille et al., 2005) . Oxidative stress has also been implicated in stimulating vasodilation through the effect of reactive oxygen and nitrogen species (Sobey et al., 1997) . The vasodilatory effects will lead to an increase in CBF and pO 2 , which may attribute to the secondary increase that is observed.
Onset of seizures may reduce oxygenation
The onset of soman-induced convulsive seizures correlates with a decrease in oxygenation in the cortex (although the pO 2 was still higher than "pre-soman"). We reason above that a hyperexcitable state would result in an elevated pO 2 . However, seizures arise when neurons are in both a state of hyperexcitability and hypersynchrony (Fisher et al., 2005) . This condition is highly metabolically demanding (Duffy et al., 1975) . We know that there is an increase in CBF (Goldman et al., 1993; Shih and Scremin, 1992) and metabolism (McDonough et al., 1983; Shih and Scremin, 1992) after soman-induced convulsive seizures, but if the demand is too high for supply then we would expect a decline in pO 2 . Such a decline with seizure has been termed the "epileptic dip" (Bahar et al., 2006; Suh et al., 2005) . Similar decreases in cortical pO 2 at or near onset of seizures were reported in epilepsy patients, where an increase in cerebral oxygenation has preceded seizures (Moseley et al., 2012; Seyal, 2014; Slone et al., 2012; Zhao et al., 2007) .
There may be more factors involved. There is evidence for abnormal vascular regulation in seizures (Farrell et al., 2016; LealCampanario et al., 2017; Zhao et al., 2011) . Near the onset of seizures, vasoconstriction (Leal-Campanario et al., 2017; Zhao et al., 2011) would reduce CBF and lead to a decrease in pO 2 if CMRO 2 were to remain high.
Vasoconstriction can be long lasting. In a study using both electrically-induced and convulsant-induced seizures, both hypoxia and hypoperfusion were recorded following the termination of seizures (Farrell et al., 2016) . In our study, we did not observe hypoxia following seizures. Except for the rats that unexpectedly died during pO 2 recording, pO 2 in the cortex and hippocampus never dropped below the severe hypoxic threshold as was reported in the previous study (where pO 2 regularly declined to <10 mmHg) (Farrell et al., 2016) . This is likely due to a difference in the method of inducing seizures. Brief electrical stimulation in a non-epileptic animal results in a relatively short duration seizure and a rapid return to the non-epileptic state. Whereas following soman administration, the compound will continue to keep the brain in a hyperexcitable state and cause brain damage. We expect similar results to the chemically-induced seizure experiment once soman has been hydrolyzed and rats exhibit spontaneous recurrent seizures (de Araujo Furtado et al., 2010) .
The decrease in hippocampal pO 2 after seizure onset was not as evident compared to the cortex. The secondary increase in the hippocampus did not reflect the time point when early soman related symptoms appeared. The temporal delay between the cortex and hippocampus pO 2 increase may be from a difference in neuronal innervation affecting vascular response. Areas surrounding a seizure focus showed a difference in vascular regulation (vasoconstriction and vasodilation) and metabolism (Zhao et al., 2011) suggests pO 2 changes depending on the onset site. The hippocampus receives projections from the medial septum and the entorhinal cortex. The medial septum is a speculated site for the generation of soman-induced convulsive seizures. The entorhinal cortex relays seizures that have been evoked from the area tempestas (Halonen et al., 1994) , another speculated somaninduced seizure onset site.
Oscillating changes in oxygenation in the first hour
Oscillating changes in oxygenation after soman-induced convulsive seizures are similar to a status epilepticus model (Kreisman et al., 1983) . In the cortex, following the initial gradual decline in pO 2 following the onset of seizures, large amplitude, low frequency cycles began to appear, indicating a non-steady state. The oscillating changes in pO 2 may reflect ongoing changes in vascular regulation during status epilepticus. When seizures stop momentarily, vasodilation allows reperfusion of the tissue and increases pO 2 . At the onset of another seizure, vasoconstriction restricts blood flow.
In the hippocampus, the oscillating changes appear before the onset of seizures and become more distinct following onset. Cycling between vasoconstriction and vasodilation may be similar to the cortex. The difference in the oscillating pO 2 may be due to a regional difference in neuronal activity, changing the neurovascular response between the cortex and hippocampus (Shih and Scremin, 1992) . There was less increase in CBF relative to the increase in metabolism in the hippocampus compared to the cortex after soman-induced convulsive seizures (Shih and Scremin, 1992) . The difference in the proportional uncoupling between the cortex and hippocampus may explain why there is no direct relationship in the oscillating changes in pO 2 .
Potential link between oxygenation and pathology
Measurements at 10-24 h following soman exposure showed significantly elevated pO 2 in the hippocampus but not in the cortex. Elevated pO 2 indicates there may be changes in oxygen utilization likely due to neurodegeneration following somaninduced seizures. In rats that have been exposed to higher doses of soman (105-154 mg/kg; sc), neurodegeneration was histologically detected using Fluoro-Jade B (Apland et al., 2010; RamaRao et al., 2014) and H&E (Shih et al., 2003; Tryphonas and Clement, 1995) in the hippocampus. Although most studies use a higher dose than we have used, rats exposed to a similar dose (80 mg/kg; sc) showed neurodegeneration as early as 45 min after convulsive seizures in the hippocampus, amygdala, and piriform cortex (Myhrer et al., 2005) . Studies have shown seizures lasting more than 40 min are an important factor in the development of neurodegeneration (Baille et al., 2005; Guo et al., 2015; Lallement et al., 1993; Myhrer et al., 2005) . Histological damage in the hippocampus has also been observed in mice (172 mg/kg; sc) (Baille et al., 2005) and guinea pigs (26.6 mg/kg; sc) (Gullapalli et al., 2010) following soman-induced convulsive seizures. The sustained elevation of pO 2 over the 24 h post exposure may reflect a condition where oxygen utilization has been greatly reduced due to cell death in the hippocampus. In the cortex, the return to control pO 2 suggests that cell damage may not be as severe. This is consistent with previous reports arguing that the neocortex is less sensitive than the hippocampus to soman-related damage (Lemercier et al., 1983; Rossetti et al., 2012) .
Future directions
In the future, it will be important to link the increase in pO 2 to soman-related cell death. This linkage would support the use of oxygen measurements during the acute phase post exposure as a biomarker of future neuropathological outcome. It would also be useful to study the mechanism behind the changes in oxygenation by correlating the changes with EEG and CBF. This will allow us to correlate neuronal activity and cerebral vascular regulation with pO 2 data. Furthermore, pO 2 measurements may be useful in treatment studies to provide a sensitive biomarker of whether metabolism and blood flow have been protected. The similarity of changes in pO 2 with that observed in animal models during status epilepticus supports further work studying anti-seizure treatment.
Conclusion
Measurements of brain oxygenation provide new information on changes in the physiological status of the brain over time following soman exposure. The temporal pO 2 profile support evidence that soman-induced seizures result in irregular vascular reactivity similar to that in other seizure models. Measurements of brain oxygenation could provide a sensitive marker of exposure and could be used as a biomarker for treatment studies.
